Ligand Pharmaceuticals (LGND)
Add to Watchlists Create an Alert
27.47
-0.48 -1.72%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Ligand Pharmaceuticals News
Ligand to Present at Upcoming Investor Conferences
Business Wire May 23Ligand Pharmaceuticals Incorporated announced today that Ligand management is scheduled to present at the following upcoming investor conferences:
Ligand Pharmaceuticals (LGND) Agreement with Merck KGaA Unit Terminated
Street Insider May 20LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement
May 19SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated
PR Newswire May 17NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches ...
Ligand Pharmaceuticals Inc. Stock Upgraded (LGND)
May 15Ligand Pharmaceuticals (Nasdaq:LGND) has been upgraded by TheStreet Ratings from a sell to hold.
Ligand Pharmaceuticals Incorporated Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 8Ligand Pharmaceuticals Incorporated Management Discusses Q1 2013 Results - Earnings Call Transcript
Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 7c; Approves $5M Buyback
Street Insider May 8Ligand Announces $5M Buyback, Q1 Earnings
Benzinga May 8Ligand Reports First Quarter Financial Results
Business Wire May 8Ligand Pharmaceuticals Incorporated today reported financial results for the first quarter ended March 31, 2013, and provided an operating forecast and program updat
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| LGND | 27.47 | -0.48 | -1.72% | 555.86M |
New watchlist
